Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Amortization of Deferred Charges (2022 - 2025)

Historic Amortization of Deferred Charges for HeartSciences (HSCS) over the last 3 years, with Q4 2025 value amounting to $263880.0.

  • HeartSciences' Amortization of Deferred Charges changed N/A to $263880.0 in Q4 2025 from the same period last year, while for Oct 2025 it was $593730.0, marking a year-over-year change of. This contributed to the annual value of $285870.0 for FY2025, which is 17594.96% up from last year.
  • HeartSciences' Amortization of Deferred Charges amounted to $263880.0 in Q4 2025.
  • HeartSciences' 5-year Amortization of Deferred Charges high stood at $263880.0 for Q4 2025, and its period low was $20719.0 during Q1 2024.
  • Over the past 3 years, HeartSciences' median Amortization of Deferred Charges value was $109950.0 (recorded in 2025), while the average stood at $114085.0.
  • Data for HeartSciences' Amortization of Deferred Charges shows a peak YoY increase of 43067.23% (in 2025) and a maximum YoY decrease of 43067.23% (in 2025) over the last 5 years.
  • Quarter analysis of 3 years shows HeartSciences' Amortization of Deferred Charges stood at $61381.0 in 2022, then plummeted by 66.25% to $20719.0 in 2024, then surged by 1173.61% to $263880.0 in 2025.
  • Its Amortization of Deferred Charges was $263880.0 in Q4 2025, compared to $109950.0 in Q3 2025 and $109950.0 in Q2 2025.